Healthcare Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Press Releases.

Press releases published on May 19, 2026

ParaFlight Aviation and DonorLink Forge Mission-Driven Alliance to Strengthen the Organ Transplant Ecosystem
MapHabit Launches Map Builder (Driven by AI) to Help Caregivers and Clinicians Create Support Maps Faster
Thrive Buildings Partners with CPower to Bring Safe, Scalable Demand Management to Critical Environments
IVF Florida celebrates 40 years of advanced fertility care and family building across Florida
Dr. Sam Speron Highlights Trend Toward Natural Results in Eyelid Surgery
BELR Subsidiary 4BiddenKnowledge to Bring the 4BK BioKey™ Educational Breath Biomarker Wellness Device to Market
As CBD Gains Legitimacy in Senior Wellness, 55plus CBD Launches Educational Dosage Calculator
SlimTide Claims Evaluated: The Baking Soda Water Shot Gelatin Trick for Losing Weight Naturally by Slim Tide
PF Warriors, Patients, Caregivers, Engage with Doctors, Researchers, Companies at American Thoracic Society Conference
AI-based Clinical Trials Solution Providers Market to Reach US$13.9 Billion by 2033 | Persistence Market Research
Thumbay Group Breaks Ground in Ajman First Private Thumbay Veterinary Hospital & Thumbay College of Veterinary Medicine
Beckenbodenschwäche und Inkontinenz: Wie Ihr Hausarzt Dr. Dorigoni in München mit innovativen Therapien helfen kann
CAIRSPlan 2.0 Launches: Brisbane Surgeons Unveil Major Rebuild of World's Leading CAIRS Surgical Planning Platform
Telehealth Market To Witness Substantial Growth, 2026-2033 | Medtronic plc, Vidyo, Inc, Cisco Systems, Inc
Ruya Partners exits GymNation, $100m refinancing by HPS / BlackRock
NewEra Medical Aesthetics Now Offers ellacor® 2.0. The First Non-Surgical Treatment to Remove Excess Skin
SNU Eye Clinic Korea and Nagoya Eye Clinic Japan Sign Global Vision Correction Partnership
Chris Littel joins Brentwood Advisory Group
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)
Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.